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Abstract 
Objectives 
Medically unexplained symptoms (MUS) are a common presentation in medical practice, and 
are associated with significant morbidity and high levels of service use.  Most research exploring 
the attitudes and training of doctors in treating patients with unexplained symptoms has been 
conducted in primary care.  This study aims to explore the ways in which doctors working in 
secondary care approach and manage patients with medically unexplained symptoms. 
Methods 
Design 
Qualitative study using in-depth interviews and thematic analysis. 
Setting  
Three hospitals in the North Thames area. 
Main outcome measures 
Physicians’ approach to patients with medically unexplained symptoms and their views on 
managing these patients 
Participants 
Twenty consultant and training grade physicians working in cardiology, gastroenterology, 
rheumatology and neurology. 
Results  
There was considerable variation in how the physicians approached patients who presented 
with MUS. Investigations were often ordered without a clear rationale and the explanations 
given to patients when results of investigations were normal were highly variable, both within 
and across specialties.   The doctor’s level of experience appeared to be a more important factor 
in their investigation and management strategies than their medical specialty. Physicians 
reported little or no formal training in how to manage such presentations, with no apparent 
consistency in how they had developed their approach.  Doctors described learning from their 
own experience and from senior role models.  Organisational barriers were identified to the 
effective management of these patients, particularly in terms of continuity of care. 
Conclusions 
Given the importance of this topic, there is a need for serious consideration as to how the 
management of patients with MUS is included in medical training and in the planning and 
delivery of services. 
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Introduction 
Medically unexplained symptoms (MUS) are a common presentation in medical practice. In a 
study based across a variety of outpatient clinics in two London hospitals, around 50% of 
patients had not received a biomedical diagnosis for their symptoms three months after they 
were first seen (1). 
Such patients often experience significant morbidity, with increased rates of anxiety, depression 
and impaired social functioning (2), and high levels of service use and investigation costs (3). The 
annual additional cost to UK health services of MUS was estimated in 2008-9 at £3 billion, 
including primary and secondary care use, accounting for approximately 10% of the annual NHS 
spending for the working age population.  Taking into account quality of life and sickness 
absence, wider costs to the economy were estimated at over £14 billion (4).   
There are a variety of possible approaches to the investigation and management of patients 
presenting with physical symptoms that cannot be adequately explained by a physical disease.  
Doctors may explore associated psychological, physical and social factors separately or may 
attempt to integrate them.  There is consensus that repeated referral and investigation is not 
helpful, is likely to be costly and may lead to worse outcomes (5), although  clinicians  need to 
balance this with the risks of not detecting a disorder.  Recognition of the potential for harm, 
and the significant cost implications of unnecessary tests and treatment, has led to international 
efforts to help doctors select appropriate investigations and interventions, such as the Choosing 
Wisely initiative in the USA (6). This encourages carefully considering the most clinically 
appropriate and cost-effective use of investigations, with implications for the management of 
MUS . 
Most international research exploring the attitudes and training of doctors in treating these 
patients has been conducted in primary care with general practitioners (GPs)(7),(8).  The 
attitudes of secondary care physicians to MUS have not previously been examined.   This study 
aimed to explore the ways in which doctors working in secondary care approach and manage 
such patients. 
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Methods 
Study design 
Qualitative study with in-depth interviews.    
Setting and participants 
We approached consultant and training grade physicians working in cardiology, 
gastroenterology, rheumatology and neurology in three different hospitals in the North Thames 
area. These four medical specialties were identified from a previous study as having the highest 
prevalence of clinical cases with MUS (1).   
Participants were purposively sampled from staff lists provided by the hospitals, aiming to 
achieve as wide a variation of views as possible across specialities, level of experience and 
setting.  Participants’ gender, ethnicity, and experience in other specialties were also monitored 
in order to achieve maximum diversity.   
Data collection 
A topic guide for the interviews was developed by the research team, informed by existing 
literature We did not provide a particular definition for MUS, instead seeking to understand 
participants’ own understanding of this issue. Interviews were conducted until saturation on key 
themes was reached, which occurred after twenty interviews. In recognition of the time spent 
being interviewed we offered a book token to participants. Written informed consent was 
obtained from all participants prior to conducting the interview.  The interviews were all 
conducted by one researcher (AW), at the participants’ place of work, and lasted for an average 
of 45 minutes.  Interviews were conducted by a doctor, this aimed to maximise participants’ 
willingness to share their views on this issue.  Interviews were recorded and transcribed 
verbatim. 
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Analysis 
The study team was comprised of three academic general practitioners (AW, KW and MB) and 
one social scientist (KL) , with experience in qualitative research and  a particular interest in this 
topic.  All members reviewed each transcript independently. A thematic framework was 
developed and agreed by consensus, identifying key issues, concepts and themes.   Data from 
the interviews was organised using Microsoft Excel charts and analysed using the ‘framework’ 
approach, identifying key themes and their meanings. (9). Data were analysed comparatively 
and disconfirming evidence searched for. The analysis and interpretation remained grounded in 
the data at all times (9).  
Results 
In-depth interviews were completed with twenty physicians;  11 consultants and 9 specialty 
trainees (see Table 1).  All worked  at least 50% of the week in NHS clinical practice and all were 
involved in teaching medical students.  Trainees were engaged in further training in their 
particular specialty and all were at their third year of specialist training (ST3) level or above.  All 
participants worked in outpatient clinics, ranging from one to four clinics per week.  32% of 
physicians  invited to participate responded, with no apparent difference in specialty, grade and 
gender of non-responders as compared with those interviewed. 
<Table 1 here>  
The physicians interviewed described examples of patients presenting with unexplained 
symptoms which varied according to specialty (see Box 1), the impact of managing such patients 
on themselves, their views about their role, strategies for carrying out investigations and for 
providing explanations, and perceived barriers to effective management. 
<Box 1 here> 
All the doctors interviewed recognised that presentations with unexplained symptoms were a 
significant part of their workload.  Most estimated that they saw at least one or two such 
patients in any routine outpatient clinic. Several doctors, from all specialities, described mixed 
presentations of symptoms that were partly explicable by organic pathology and partly 
unexplained.   
Clinician attitudes and approach 
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Doctors’ perceptions of their role when dealing with such patients varied considerably and there 
was a range of attitudes relating to the impact of working with patients with MUS. These had 
often been formed over time and there were clear associations with the level of experience of 
the clinicians. Most spoke of finding such patients challenging, but this could be in either 
positive or negative ways.   
Some participants who found managing patients with MUS exhausting described them as very 
time-consuming.   Several doctors in training, as well as a few  consultants, felt unsatisfied or 
frustrated at times when they felt unable to treat  patients effectively.   
Challenging perhaps because it doesn’t fit the medical mould… It’s harder when it’s 
normal [results] and yet they’ve still got symptoms, which you can’t explain away 
through a medical process. [Cardiology Registrar 1] 
Some felt that their role as a specialist was to exclude causes for a patient’s symptoms only 
relating to their own specialty, and not necessarily to go beyond that. This view was held by 
doctors from a range of specialties and experience. 
I see my main function in the heart clinic as reassuring that it isn’t coming from their 
heart and that it isn’t something life threatening, rather than telling them exactly what it 
is.      [Consultant Cardiologist 2] 
Several respondents talked about the importance of providing reassurance and many spoke 
about the importance of building a relationship, developing trust and making sure patients felt  
their concerns were heard. These were mostly more experienced doctors from all specialties: 
I think the key is to have a trusting relationship with the patient, that they’re confident, 
they’re happy that you have their best interests at heart.  That you’re looking at and 
believing them. [Consultant Gastroenterologist 1] 
A distinct group of three more experienced doctors found dealing with such patients a positive 
challenge.  These doctors also perceived difficulties in managing patients with MUS, but said  
they found it rewarding.  
I like them.  I think it’s a challenge actually…managing them over quite a long period of 
time you can, you feel as if you’re achieving something … 
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[Consultant Rheumatologist 3] 
These  senior consultants considered they had  developed particular expertise in working with 
such  patients and so would be likely to ‘attract’  them or have them referred  for advice.    
How doctors develop their approach 
When asked how they had developed their personal approach to managing patients with MUS, 
the doctors described a variety of influences. Most commonly, they spoke of learning by 
example from colleagues they had observed practicing:  
You develop it over time through positive and negative role models, what to do and what 
not to do.  [Neurology Registrar 2] 
Several  more experienced doctors described a process of trial and error and of learning from 
their own mistakes, with time being important in allowing experience to develop.  Almost all 
those interviewed recalled receiving very little or no teaching about this topic in undergraduate 
or postgraduate training and relying  on informal or ‘on the job’ experience:   
Nobody’s ever taught me this.  This is all stuff that I’ve pretty much, it’s unstructured and 
it’s pretty much what I’ve learnt as I’ve gone along. [Gastroenterology Registrar 3] 
Doctors in training posts said  they rarely had the opportunity to observe their seniors 
consulting in outpatient clinics and  that they themselves were very rarely observed in clinic as 
part of their training: 
I don’t think I’ve ever been taught anything in an out-patient clinic directly.  I might have 
gone to present a patient to the consultant, but no one’s actually sat and watched me 
consult.  No one has shown any interest in my consulting technique.   
[Cardiology Registrar 4] 
All the clinicians reported receiving no  feedback on the effectiveness of their approach to 
managing patients with MUS and many considered  they would find this very useful. 
 
Rationale for Investigations 
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The doctors described considerable variations in their approach to the investigation of patients 
presenting with MUS, giving   different reasons for their actions ,  but with a  general  emphasis 
on ordering a range of investigations and then discussing the results with the patient rather than 
being more selective at the outset.  
“Standard tests” for all 
Some clinicians had a blanket approach to the initial investigation of patients 
Everybody gets a full panel of blood tests as standard.  And then brain imaging, 
depending on what we’re looking for… EEG… and so on.  [Neurology Registrar 5] 
Taking the patient seriously and facilitating further management 
[Testing]  clears the deck for, in my view, an adult exchange of views where their various 
concerns, their expectations, their ideas can be systematically examined and discussed  
[Consultant Gastroenterologist 8] 
Providing reassurance for patient, and/or for doctor 
I think whether or not you do a test on a patient, to a small degree, is driven by how 
much a patient needs the reassurance.  [Cardiology Registrar 1] 
Concern about missing organic pathology 
Several of those interviewed, particularly  more junior ones, indicated that they were likely to 
arrange more investigations for patients with unexplained symptoms because of their fear of 
missing significant organic pathology 
… you always do more tests …you do every test you can think of to make sure you’re not 
missing anything.  People I think are functional cause a great deal of anxiety because I’m 
nervous about the fact that I think they’re functional and I’m very worried that I’m just 
missing something. [Neurology Registrar 6] 
Threat of litigation 
This fear of missing an organic diagnosis was compounded by the perceived threat of litigation if 
an organic diagnosis was missed  
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I over-investigate the vast majority of these patients.  The number of times I’ve actually 
found an abnormality… really minimal…I think if we were in an era where the lawyers 
weren’t so prominent, you know, advertising their services for patients who come out of 
A&E and that kind of thing, then I probably wouldn’t be so defensive.                      
[Consultant Rheumatologist 7] 
Negative aspects of investigations 
Several of those interviewed also discussed the potential for negative consequences from 
performing investigations.  For example, that organising tests to reassure the patient could in 
fact generate more anxiety, particularly where scans revealed incidental findings 
…if patients get a lot of tests and just by statistical chance they will have an 
abnormality… [Consultant Neurologist 5] 
They described sharing with patients in advance that tests could be potentially dangerous and 
unnecessary and that there were limitations on what could be tested for. Some also highlighted 
the potential for wasting resources.   
…you’ve got to have a strategy … at some stage be quite firm and say, ‘I don’t think I 
want to do any more tests.  I think they are unnecessary.  I think potentially they’re 
dangerous, every test has a risk.  [Consultant Cardiologist 9] 
Types of explanations used  
Those  interviewed described using various  strategies to explain what they considered  the 
problem to be,  possible underlying mechanisms and ways of taking things forward. We have 
divided these into three main categories:  
Reassurance / Normalising: 
Many told patients directly that the cause for their symptoms was unknown, some mentioning 
the current inadequacies of medicine to provide an explanation.  This approach was particularly 
taken by trainees.  
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I’m sure you have that symptom but we can’t explain it.  What we do know is it’s not 
something worrying or dangerous or life threatening…And it’s something that I think we 
can manage conservatively. [Rheumatology Registrar 7] 
Physiological / Mechanistic: 
Explanations of biological function were frequently given , by both consultants and trainees,  
aimed at helping patients understand how the potential cause of their symptoms.   The doctors 
aimed to put their symptoms into a context which the patient could understand, for example 
describing normal responses to stress and hyperventilation.  A few mentioned checking the 
patient’s understanding of this explanation.  Some made use of leaflets or drew diagrams: 
Enabling and improving function  
Several clinicians of different levels of experience described using explanatory strategies which 
aimed to incorporate the importance of promoting functional recovery, helping patients to 
achieve control over their symptoms   
…we’ve looked at the nerves and the electrics and all the messages are getting through.  
…and I always couch it in a positive way…We have to find a way in order to get you to 
make your leg work again. [Neurology Registrar 4] 
Those doctors who had described their role as mainly to exclude organic pathology  tended to 
describe giving normalising explanations and trying to provide reassurance. This was also the 
case for doctors in training who had mentioned finding such consultations challenging.   
However, interviewees who had described finding such patients a positive challenge and those 
who felt they had developed particular experience in the area tended to describe giving more 
physiological or enabling explanations.  In particular, neurology consultants and trainees 
reported using enabling explanations, mentioning concepts of relearning, retraining and 
adaptation. 
Barriers to effective management of patients with MUS 
Several doctors contrasted their ideal approach to managing these patients with the realities of 
their current outpatient practice, which they felt impacted negatively in many cases.   
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Time pressures 
Limited time in out-patient settings to form effective relationships with patients was seen as a 
particular problem  
These patients take time…To treat them properly you need to give them more time 
than anybody else.  You need to develop a relationship with them.  
 [Neurology Registrar 1]  
 
Lack of continuity 
Doctors in training particularly found it difficult to see the same patient more than once, so they 
would have little idea about  longer-term patient outcomes. 
…the difficulty being a registrar in the NHS is.. you rotate through various clinics, so I will 
not have a longstanding relationship with this patient, which is extremely unfortunate 
because I can’t really take it any further  [Neurology Registrar 2] 
Patients were frequently seen once in a clinic and then discharged back to their GP with  their 
results,  without having any specialist review  to explain any negative results,  which they would 
only hear about by letter or telephone call. This was perceived as a problem in  managing  such 
patients.   
Limited management options  
Some clinicians described a lack of effective therapeutic options.  Access to psychology and 
liaison psychiatry was limited, and even where available several doctors mentioned difficulties in 
broaching the idea of involving a psychologist with patients. 
 
 
Discussion 
The physicians interviewed identified patients with medically unexplained symptoms (MUS) as 
forming a significant part of their workload. There was considerable variability in how the 
doctors approached these patients and their level of experience appeared to be a more 
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important factor in their investigation and management strategies than their medical specialty. 
The exception  was neurologists, who tended to give enabling explanations at all levels of 
experience.   There was a general tendency to order batches of investigations, although the 
reasons given  varied.  Physicians reported little or no formal training in how to manage such 
patients, with  no consistency in how they  had developed their approach.  Doctors described 
learning from their own experience and from senior role models.  Organisational barriers were 
identified to the effective management of these patients, particularly in terms of continuity of 
care. 
Comparison with existing literature  
Many of those interviewed found the management of patients with MUS challenging, and for 
some doctors in training this was a source of considerable anxiety, particularly around missing 
serious pathology.  These findings are similar to previous work with GPs  (8), and GP trainees 
(10).  However, a recent study of  patients seen in a variety of secondary care settings found 
that in 120 cases diagnosed as having bodily distress syndrome (another term for MUS), none 
had been wrongly diagnosed, although five had comorbid medical problems which had not been 
optimally managed (11).  A recent study exploring  medical student attitudes also found a  lack 
of formal training in MUS, and  senior role models to be influential in shaping students’ attitudes 
and approach (12). 
Patients’ presenting symptoms varied according to  specialty, although with  some overlap in 
areas such as pain and fatigue, consistent with other studies  (13),(14). Several  doctors 
interviewed highlighted the importance of attempting to understand the patient’s expectations, 
as  in a  recent review of the literature on effective communication with patients presenting 
with MUS (15). 
Investigations were initiated for a variety of reasons, and might be as much because of doctors’  
own anxiety about the consequences of missing an organic diagnosis as for clinical indications.  
While negative results are commonly considered  reassuring to patients, a recent systematic 
review found  this may not be the case (16) and that  for symptoms with a low risk of serious 
illness, diagnostic tests do little to reassure patients or reduce anxiety in either the short or  long 
term.   
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Defensive medicine and fear of litigation affecting clinical practice are  widely recognised, as is 
the potential for incidental findings causing new anxieties for  patients as mentioned by several 
respondents in our study (17).  Detsky  proposes that clinicians should promote the appropriate 
use of ‘restraint’ with  investigations and  consider all their  potential consequences,  including 
iatrogenic harm.  He argues that, senior clinicians are well placed to do this and to demonstrate  
the appropriate use of restraint (18).    
Those interviewed described using a variety of explanations to account for patients’ symptoms, 
with several participants suggesting the use of ‘empowering explanations’ which  have been 
found to be well received by patients (19).  However others, in particular doctors in training, 
reported offering more limited explanations, i.e. giving feedback about negative findings, but 
without giving any further explanation for the symptoms experienced.  The approach of these 
doctors was consistent with a previous study of physicians that found less patient-centred 
communication in  MUS cases (20). 
 
Strengths and limitations 
This is the first study we are aware of exploring the views of hospital physicians across different 
medical specialties about managing patients with MUS. There was the potential for selection 
bias with the sampling strategy  used, and  doctors with a particular interest in this topic may 
have been more likely to respond to an invitation for interview.  There were two experienced 
clinicians who participated in the study, who stated  a special interest in this area. However, a 
purposive sampling strategy aimed to maximise diversity across experience, setting and 
demographic characteristics within four medical specialities with a high prevalence of MUS   
There was deliberate probing for negative attitudes, and participants expressed a wide range of 
views.  Participants were aware that the interviewer was a doctor, and this may have influenced 
the attitudes and experiences that they shared.  It is possible that doctors who declined to 
participate have views  not represented here.   
 
Meaning and Implications 
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Inconsistencies in the approach provided by different clinicians risks patients being given 
contradictory messages and potentially losing confidence in their doctors.  A number of 
experienced consultants were identified who found managing such patients a positive challenge 
and who felt they had developed effective management strategies, with  providing some 
continuity of care considered  important. This needs to be explored further and assessed with 
objective data on patient outcomes..  However, with the arrangements for clinics and training  
described, it is unclear how such experience can currently be passed on to colleagues and 
trainees in any consistent or reliable way.  It is potentially beneficial for junior doctors to have 
the opportunity to observe their seniors consult, to be observed themselves and to receive 
feedback from both colleagues and patients.   
There appeared to be little consistency of approach to such  patients, either within or across 
specialties, and few of the doctors reported receiving any formal training in this area, with a 
brief mention in a lecture at the most.  Given the associated patient morbidity and functional 
impairment,  with the resulting cost implications, serious consideration needs to be given to 
including the topic in the training and continuing professional development of  all doctors. Such 
training should be provided in an evidence-based and consistent way and the impact on patient 
outcomes assessed. 
 We also  need to improve our understanding of  the perceived indications for the ordering of 
investigations and  recommendations for referrals and interventions , as there is clearly 
currently considerable variability in current practice, often without a clear underlying rationale.  
This is  particularly important given the potential harm from unnecessary investigations, , as well 
as the considerable healthcare costs . 
Many  interviewees identified  the current organisation of outpatient clinics as making managing 
patients with MUS more difficult.  In developing models of care, the importance of continuity 
and the longer term benefits of investing sufficient time to ensure  patients receive satisfactory 
explanations for their symptoms needs to be recognised.  
Conclusions 
Patients with MUS experience significant morbidity and have high levels of service use and 
associated health expenditure.  Our study reports very variable approaches to their investigation 
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and management.   There is a need for serious consideration of how the management of 
patients with MUS is included in medical training, and in the planning and delivery of services. 
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Table 1 – Participant Characteristics 
 
 
Participant Characteristics  
   
Specialty Neurology 5 
 Cardiology 5 
 Gastroenterology 4 
 Rheumatology 6 
   
Hospital A 6 
 B 8 
 C 6 
   
Gender Female 8 
 Male 12 
   
Grade Consultant 11 
 Trainee 9 
  
 
Years post-qualification Less than 10 5 
 10 to 19 8 
 20 to 29 5 
 Over 30 2 
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Box 1 Examples of unexplained symptoms reported by specialties 
 Examples of unexplained symptoms reported by specialties 
Gastroenterology 
Abdominal pain, nausea, constipation 
Rheumatology 
Chronic or generalised pain syndromes, Fibromyalgia 
Cardiology  
Chest pain, palpitations  
Neurology 
Non-epileptic seizures, weakness, paralysis, movement disorders,  
sensory disturbance, dizziness, non-organic blindness, loss of consciousness.   
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